How to Buy Adaptive Biotechnologies Corporation Common Stock (ADPT) Stock

Where to buy ADPT

13 brokers in our matrix offer ADPT. Verify availability and current fees with each broker before trading.

Broker	Commission	Fractional	Extended	Overnight	Options	OTC access
Charles Schwab (thinkorswim)	$0	Schwab Stock Slices, S&P 500 only, ≥ $5/slice, up to 30 at once		~1,130	$0.65	Most (3/5)
E*TRADE (Morgan Stanley)	$0 listed			~20	$0.65	Most (4/5)
Fidelity	$0	Stocks by the Slice, 7,000+ stocks/ETFs, from $1			$0.65	Partial (2+0)
Firstrade	$0	~4,000+ tickers, ≥ $5		~1,200	$0	Most (4/5)
Interactive Brokers	$0 (Lite) / per-share (Pro)			~10,000	per-contract pricing	Full
Merrill Edge	$0				$0.65	Most (3/5)
Moomoo	$0				$0	Limited only
Public.com	$0				rebate model	Limited only
Robinhood	$0	≥ $1 stocks, market cap ≥ $25M		~1,134	$0	None
SoFi Active Investing	$0				$0	Partial (1+2)
tastytrade	$0 stocks				$1.00 open, $0 close (capped at $10 per leg)	Limited only
TradeStation	$0 listed				$0.50 / $0.60	Most (4/5)
Webull	$0				$0	Limited only

24-Hour / Overnight trading

ADPT may be eligible for overnight trading via Charles Schwab (thinkorswim), Interactive Brokers, Robinhood, E*TRADE (Morgan Stanley), Webull, Moomoo, Firstrade. Each broker maintains its own eligibility list — confirm before placing an order.

About Adaptive Biotechnologies Corporation Common Stock

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Sector

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Employees

624

Headquarters

SEATTLE, WA

Listed

2019-06-27

Market cap

$2.18B

Frequently asked

Where can I buy Adaptive Biotechnologies Corporation Common Stock (ADPT)?

ADPT is offered by 13 brokers in our matrix, including Charles Schwab (thinkorswim), E*TRADE (Morgan Stanley), Fidelity, Firstrade, Interactive Brokers. Compare commissions, fractional eligibility, and overnight availability in the broker matrix above.

Can I buy ADPT after hours or overnight?

Yes. ADPT is on the 24-hour eligibility list for Charles Schwab (thinkorswim), Interactive Brokers, Robinhood, E*TRADE (Morgan Stanley), and others. Overnight sessions route through ATSs with wider spreads and limit-orders only.

Does Robinhood offer ADPT?

Yes. Robinhood offers ADPT as a regular exchange-listed security.

Does Fidelity offer ADPT?

Yes. Fidelity offers ADPT as a regular exchange-listed security.

Does Webull offer ADPT?

Yes. Webull offers ADPT as a regular exchange-listed security.

Is ADPT optionable?

Yes. ADPT has listed options contracts. Per-contract pricing varies by broker — see the Options column in the matrix.

Is there a tokenized version of ADPT?

Not in our current dataset. The tokenized stock universe (Kraken xStocks, Binance Alpha/Ondo, Robinhood EU, Hyperliquid HIP-3) is expanding quickly — we refresh quarterly.

Can I buy a fractional share of ADPT?

Yes. Multiple brokers in the matrix support fractional shares for ADPT — see the Fractional column above for per-broker eligibility and minimums.